Large-scale testing (Phase 3)Looking for participantsNCT07154706
What this trial is testing
Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)
Who this might be right for
Non-small Cell Lung Cancer (NSCLC)
Nuvation Bio Inc. 180